Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Globus Medical Inc. Class A Common Stock (GMED) vs Kroger Co (KR) Price & Performance

Globus Medical Inc. Class A Common StockTrade

Price performance (Past 24H)

Key statistics

Globus Medical Inc. Class A Common Stock vs Kroger Co — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while Kroger Co trades at $63.42 (market cap $35.87B). The key difference: Kroger Co is far larger — about 3.5× Globus Medical Inc. Class A Common Stock's market cap, and Kroger Co pays a 2.57% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Kroger Co for 109 Days on average.

GMEDKR
Market Cap
$10.25B$35.87B
Volume
1,108,1248,902,665
Sector
HealthConsumer Staples
52-Week High
$96.82$75.60
52-Week Low
$58.33$55.53
Typical Hold Time
0 Days109 Days
Enterprise Value
$9.76B$57.29B
Dividend Yield
—2.57%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Globus Medical Inc. Class A Common Stock

Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.

GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.

Kroger Co

Kroger (KR) trades at $63.09, up 0.85% today, with a bullish technical signal and strong analyst consensus. The stock shows robust fundamentals with a low P/S of 0.26 and positive cash flow trends, though net income margin is thin at 0.73%. Recent news highlights digital growth and a strategic shift toward everyday low prices, while earnings have mostly beaten expectations.

Outlook is cautiously optimistic with a $70.62 consensus price target, but risks include integration challenges from acquisitions and cost pressures. The stock offers value with a dividend yield, yet investors should weigh slower sales guidance against operational improvements for near-term performance.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GMED
100% Buy0% Sell
Avg holding period · 0 Days
KR
100% Buy0% Sell
Avg holding period · 109 Days

Top news

Latest headlines on both assets

About Globus Medical Inc. Class A Common Stock

Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.

Read more on GMED →

About Kroger Co

Kroger is the leading American grocer, with 2,726 supermarkets operating under several banners throughout the country as of the end of fiscal 2021. Around 83% of stores have pharmacies, while nearly 60% also sell fuel. The company also operates roughly 120 fine jewelry stores. Kroger features a leading private-label offering and manufactures around 30% of its own-brand units (and more than 40% of its grocery own-label assortment) itself, in 33 food production plants nationwide. Kroger is a top-two grocer in most of its major markets (as of early 2021, according to company data). Virtually all of Kroger's sales come from the United States.

Read more on KR →